| Dr Sasan Ryan Raissi, MD | |
|
676 N Saint Clair St Ste 600, Chicago, IL 60611-2981 | |
| (312) 695-0070 | |
| (312) 695-0063 |
| Full Name | Dr Sasan Ryan Raissi |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 22 Years |
| Location | 676 N Saint Clair St Ste 600, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346537826 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Thomas West Hospital | Nashville, TN | Hospital |
| Tennova Healthcare-clarksville | Clarksville, TN | Hospital |
| Saint Thomas Rutherford Hospital | Murfreesboro, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Thomas Medical Partners | 1557269354 | 519 |
News Archive
The Hill reports that as Republicans call for repeal of the law, the Obama administration is quick to push back. Writing Thursday on the White House blog, Stephanie Cutter, the president's communications guru, noted that repealing the reforms would eliminate all the patient protections that just took effect.
Rich Glynn, a straight-talking entrepreneur from South Dakota, doesn't mince words when explaining why a partnership between his fledgling goose operation and the University of North Dakota is a match made in heaven.
Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
A new study by researchers at the Harvard Medical School and the Ragon Institute of MGH, MIT and Harvard showed that obesity is not tied to the increased risk of SARS-CoV-2 infection. However, the team demonstrated that obesity is associated with increased manifestations of symptoms in mild COVID-19 infections, suggesting that obesity impacts the pathophysiology of COVID-19.
Researchers have made a giant leap towards the goal of 'bio-printing' transplantable tissues and organs for people affected by major diseases and trauma injuries, a new study reports.
› Verified 7 days ago
| Entity Name | Saint Thomas Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437194669 PECOS PAC ID: 1557269354 Enrollment ID: O20031230000470 |
News Archive
The Hill reports that as Republicans call for repeal of the law, the Obama administration is quick to push back. Writing Thursday on the White House blog, Stephanie Cutter, the president's communications guru, noted that repealing the reforms would eliminate all the patient protections that just took effect.
Rich Glynn, a straight-talking entrepreneur from South Dakota, doesn't mince words when explaining why a partnership between his fledgling goose operation and the University of North Dakota is a match made in heaven.
Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
A new study by researchers at the Harvard Medical School and the Ragon Institute of MGH, MIT and Harvard showed that obesity is not tied to the increased risk of SARS-CoV-2 infection. However, the team demonstrated that obesity is associated with increased manifestations of symptoms in mild COVID-19 infections, suggesting that obesity impacts the pathophysiology of COVID-19.
Researchers have made a giant leap towards the goal of 'bio-printing' transplantable tissues and organs for people affected by major diseases and trauma injuries, a new study reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sasan Ryan Raissi, MD 4230 Harding Pike, Ste 430, Nashville, TN 37205-4901 Ph: (615) 269-4545 | Dr Sasan Ryan Raissi, MD 676 N Saint Clair St Ste 600, Chicago, IL 60611-2981 Ph: (312) 695-0070 |
News Archive
The Hill reports that as Republicans call for repeal of the law, the Obama administration is quick to push back. Writing Thursday on the White House blog, Stephanie Cutter, the president's communications guru, noted that repealing the reforms would eliminate all the patient protections that just took effect.
Rich Glynn, a straight-talking entrepreneur from South Dakota, doesn't mince words when explaining why a partnership between his fledgling goose operation and the University of North Dakota is a match made in heaven.
Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
A new study by researchers at the Harvard Medical School and the Ragon Institute of MGH, MIT and Harvard showed that obesity is not tied to the increased risk of SARS-CoV-2 infection. However, the team demonstrated that obesity is associated with increased manifestations of symptoms in mild COVID-19 infections, suggesting that obesity impacts the pathophysiology of COVID-19.
Researchers have made a giant leap towards the goal of 'bio-printing' transplantable tissues and organs for people affected by major diseases and trauma injuries, a new study reports.
› Verified 7 days ago
Dr. Sorin C Danciu, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |